Literature DB >> 10540351

Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice.

X Martinez1, X Li, J Kovarik, M Klein, P H Lambert, C A Siegrist.   

Abstract

Early life responses to respiratory syncytial virus (RSV)-F DNA and RSV-F protein immunization were studied in murine models of neonatal immunization. RSV-F DNA induced similar antibody (Ab) responses, antigen-specific IFN-gamma production and cytotoxic T lymphocyte (CTL) responses in 1-week-old and adult BALB / c mice. In contrast, RSV-F protein induced much higher IL-5 responses in early life. Both vaccines elicited Ab and CTL responses in spite of maternal Ab, but with distinctive kinetics. Sequential RSV-F DNA priming / protein boosting primed 1-week-old mice for RSV-F-specific CTL responses, reduced IL-5 production and enhanced Ab responses. In contrast, IL-5 exceeded IFN-gamma responses when young mice were primed with protein and boosted with DNA. Last, when protein and DNA immunization were combined, a single vaccine dose induced early Ab responses, preferential IL-5 responses but strong CTL responses. Sequential or combined DNA / protein immunization thus represent interesting strategies for early life immunization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540351     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3390::AID-IMMU3390>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  Matthew J Giacalone; Juan C Zapata; Neil L Berkley; Roger A Sabbadini; Yen-Lin Chu; Maria S Salvato; Kathleen L McGuire
Journal:  Vaccine       Date:  2006-12-26       Impact factor: 3.641

2.  Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages.

Authors:  Miriam V Liscovsky; Romina P Ranocchia; Carolina V Gorlino; Diego O Alignani; Gabriel Morón; Belkys A Maletto; María C Pistoresi-Palencia
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

3.  Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus.

Authors:  M Franchini; C Abril; C Schwerdel; C Ruedl; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

Authors:  Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Yu-Na Lee; Eun-Ju Ko; Si-Eun Yoo; Min-Chul Kim; Ki-Hye Kim; Min Kyoung Cho; Young-Tae Lee; You Ri Lee; Fu-Shi Quan; Sang-Moo Kang
Journal:  Vaccine       Date:  2014-08-27       Impact factor: 3.641

5.  Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.

Authors:  Marcela F Pasetti; Eileen M Barry; Genevieve Losonsky; Mahender Singh; Sandra M Medina-Moreno; John M Polo; Jeffrey Ulmer; Harriet Robinson; Marcelo B Sztein; Myron M Levine
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 6.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

7.  Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

Authors:  Eun-Ju Ko; Young-Man Kwon; Jong Seok Lee; Hye Suk Hwang; Si-Eun Yoo; Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Min Kyoung Cho; You Ri Lee; Fu-Shi Quan; Jae-Min Song; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Nanomedicine       Date:  2014-08-08       Impact factor: 5.307

8.  Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.

Authors:  Lingshu Wang; J Oriol Sunyer; Leonard J Bello
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

Authors:  Aude Remot; Xavier Roux; Catherine Dubuquoy; Jenna Fix; Stephan Bouet; Mohammed Moudjou; Jean-François Eléouët; Sabine Riffault; Agnès Petit-Camurdan
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

10.  Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Authors:  Yingying Xu; Pak-Wai Yuen; Jenny Ka-Wing Lam
Journal:  Pharmaceutics       Date:  2014-07-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.